Effect of metoprolol on rest and exercise left ventricular systolic and diastolic function in idiopathic dilated

I P Clements1, W L Miller

  • 1Division of Cardiovascular Disease and Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minn.

American Heart Journal
|February 15, 2001
PubMed

Insights

In idiopathic dilated cardiomyopathy (IDCM), heart rate significantly impacts systolic and diastolic cardiac function, even after beta-blockade therapy. This relationship persists during rest and exercise, highlighting heart rate

Area of Science:

  • Cardiology
  • Heart Failure Research
  • Pharmacology

Background:

  • Idiopathic dilated cardiomyopathy (IDCM) is a complex condition affecting heart muscle function.
  • Understanding the interplay between heart rate and cardiac performance is crucial for managing IDCM.
  • Previous studies suggest heart rate influences systolic and diastolic function, but its behavior under beta-blockade and exercise in IDCM requires further elucidation.

Purpose of the Study:

  • To investigate the effects of heart rate on systolic and diastolic function in patients with IDCM.
  • To determine if beta-blockade and exercise alter the relationship between heart rate and left ventricular function in IDCM patients.

Main Methods:

  • Eighteen IDCM patients were enrolled in a 3-month, double-blind, randomized trial comparing metoprolol and placebo.
  • Resting and exercise radionuclide left ventriculograms were performed before and after the 3-month treatment period.
  • These assessments evaluated left ventricular systolic and diastolic function parameters.

Main Results:

  • Metoprolol significantly reduced heart rate and improved left ventricular ejection fraction at rest and during exercise compared to placebo.
  • Exercise in the metoprolol group showed decreased heart rate, increased ejection fraction, prolonged filling time, and reduced peak filling rate.
  • Pre-treatment, heart rate correlated negatively with ejection fraction and positively with peak filling rate; these correlations persisted for peak filling rate after metoprolol treatment.

Conclusions:

  • In IDCM patients, heart rate is intrinsically linked to both systolic and diastolic cardiac function.
  • This relationship between heart rate and diastolic function remains evident even after beta-blockade treatment, both at rest and during exercise.
Abstract

Related Concept Videos

Heart Failure Drugs: β-Blockers01:22

Heart Failure Drugs: β-Blockers

β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation, vasodilation, and...
Mitral Regurgitation I: Introduction01:20

Mitral Regurgitation I: Introduction

Mitral regurgitation is characterized by the backward circulation of blood from the left ventricle to the left atrium during systole, a phase of the cardiac cycle when the heart contracts and pumps blood out of the chambers. This abnormal flow occurs primarily due to the dysfunction of the mitral valve or its supporting structures, which include the mitral leaflets, chordae tendineae, annulus, and papillary muscles.Etiology and Mechanisms:Primary Mitral Regurgitation: This type arises from...
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...